Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers

Radiotherapy and Oncology

Volumn 57, Issue 2, 2000, Pages 119-124

  Dobrowsky, Werner ^a,b   Naudé, Jonathan ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b GENERAL HOSPITAL LINZ   (Austria)

Author keywords

Accelerated fractionation; Combined radio chemotherapy; Head and neck cancer; Mitomycin C

Indexed keywords

MITOMYCIN C;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; BOLUS INJECTION; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRACTIONATION; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; SURVIVAL;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HEMATOLOGIC DISEASES; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; PROBABILITY; RADIATION DOSAGE; RADIODERMATITIS; RADIOTHERAPY; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034332792     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(00)00233-4     Document Type: Article

References (23)

1. Altered fractionation trials in head and neck cancer
2. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis
3. Radiotherapy-chemotherapy combinations in head and neck squamous cell carcinoma: overview of randomized trials
4. Hyperfractionated irradiation with and without concurrent chemotherapy for locally advanced head and neck cancer
5. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer
6. Initial results with different fractionation in head and neck cancers and correlation with cell kinetic measurements
7. Intercomparison of new and old schedules in fractionated radiotherapy
8. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale mitomycin randomized trials
9. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial
10. A randomized trial of accelerated versus conventional radiotherapy in head and neck cancer
11. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity
12. Is the 7-day accelerated treatment better than conventional 5-day irradiation of head and neck cancers?
13. Dose fractionation and regeneration in radiotherapy for cancers of the oral cavity and oropharynx: tumour dose-response and repopulation
14. Hyperfractionated photon radiotherapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx and sinuses, using radiation therapy as the only planned modality
15. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer
16. Comparison of conventional and split course radiotherapy as treatment in carcinoma of the larynx
17. Radiotherapy with thrice-a-day fractionation in a short overall time: clinical experiences
18. Meta-analysis of chemotherapy in head and neck cancer: individual patient data vs literature data
19. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo
20. Use of hypoxia-directed drugs in the therapy of solid tumors
21. Continuous hyperfractionated accelerated radiotherapy in locally advanced carcinoma of the head and neck
22. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry
23. The hazard of accelerated tumor clonogen repopulation during radiotherapy